Company / Operating Margin
LEXICON PHARMACEUTICALS, INC. Operating Margin History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-14264.9%
FY2025
5-year range
-72489.2% / -160.5%
FY2021-FY2025
Trend
+80.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2025 after 4 years of decline, reaching -14264.9%.
Based on SEC 10-K filings.
-14264.9% in FY2025 with a 10-year CAGR of -9657.8%.
Improved from -29224.8% to -14264.9% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -9657.8pp
Key checks
Key Insights
- In FY2025, operating margin increased 80.3% year-over-year.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14264.9% | +80.3% |
| FY2024 | -72489.2% | -148.0% |
| FY2023 | -29224.8% | -14570.4% |
| FY2019 | -199.2% | -24.1% |
| FY2018 | -160.5% | -14300.0% |
| FY2017 | 1.1% | +100.3% |
| FY2016 | -439.2% | +90.5% |
| FY2015 | -4607.2% | +53.7% |
| FY2014 | -9955.5% | -61.3% |
| FY2013 | -6170.6% | -216.4% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026